Aurinia settles patent dispute with Sun Pharma, ends IPR and litigation

Aurinia Pharmaceuticals Inc.

Joint motion to terminate IPR on Aurinia's U.S. Patent No. 10,286,036 filed.
Parties agree to dismiss all claims and counterclaims in patent litigation over Sun's CEQUA product.
Settlement conditional on USPTO approval of IPR termination.
No financial terms disclosed; both parties cease future actions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.